Production of metal-organic frameworks
US-2016346757-A1 · Dec 1, 2016 · US
US10421065B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10421065-B2 |
| Application number | US-201615549256-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 2, 2016 |
| Priority date | Feb 6, 2015 |
| Publication date | Sep 24, 2019 |
| Grant date | Sep 24, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a process for preparing a water splitting catalyst containing [Mn4CaO4] core structure and use thereof. The present invention provides clusters containing [Mn4CaO4] core structure by a chemical synthesis using inexpensive metal ions (Mn2+, Ca2+ ions), simple carboxyl ligands and a permanganate, performed single crystal X-ray diffraction on their space structure, and characterized their physical and chemical properties with electron spectrum, electrochemical and electron paramagnetic resonance technologies and the like. These compounds can catalyze water splitting in the presence of oxidant to release oxygen and can also catalyze water splitting on the surface of an electrode to release electrons onto the surface of the electrode to form a current.
Opening claim text (preview).
The invention claimed is: 1. A [Mn 4 CaO 4 ](R 1 CO 2 ) 8 (L 1 )(L 2 )(L 3 ) compound of Formula I, comprising an asymmetric [Mn 4 CaO 4 ] heteronuclear metal cluster skeleton core having four Mn ions and one Ca 2+ ion linked via four O 2− ions; and peripheral ligands that are eight carboxylic acid anions and three neutral ligands (L 1 , L 2 , L 3 ); wherein, R 1 is H or a C 1-8 linear or branched alkyl; the three ligands L 1 , L 2 , and L 3 are the same or different and are each independently selected from the group consisting of carboxylic acid molecules, pyridine, imidazole, pyrazine, quinoline, isoquinoline, H 2 O, alcohol molecules, ketones, nitriles, and esters, wherein two of the four Mn ions have a valance state of +3 and the other two of the four Mn ions have a valance state of +4. 2. The compound according to claim 1 , wherein the compound is electrically neutral. 3. The compound according to claim 1 , wherein the carboxylic acid anion (R 1 CO 2 − ) is selected from the group consisting of formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, and hexanoic acid. 4. The compound according to claim 1 , wherein the compound is [Mn 4 CaO 4 (R 1 CO 2 ) 8 ](L 1 )(L 2 )(L 3 ), wherein R 1 =tert-butyl; L 1 =pyridine; L 2 =L 3 =pivalic acid; [Mn 4 CaO 4 (R 1 CO 2 ) 8 ](L 1 )(L 2 )(L 3 ), wherein R 1 =tert-butyl; L 1 =L 2 =pyridine; L 3 =pivalic acid; or [Mn 4 CaO 4 (R 1 CO 2 ) 8 ](L 1 )(L 2 )(L 3 ), wherein R 1 =tert-butyl; L 1 =isoquinoline, L 2 =L 3 =pivalic acid. 5. The compound according to claim 4 , wherein the compound is [Mn 4 CaO 4 (R 1 CO 2 ) 8 ](L 1 )(L 2 )(L 3 ), wherein R 1 =tert-butyl; L 1 =pyridine; L 2 =L 3 =pivalic acid; its single crystal being monoclinic, space group being P2 1 /c1, cell parameter being a=29.317(7)Å, b=18.894(4)Å, c=29.903(7)Å, α=90.00°, β=104.609(4)°, γ=90.00°, Z=8, volume being 16028(7)Å 3 , and its structure being shown as in Formula I-1: [Mn 4 CaO 4 (R 1 CO 2 ) 8 ](L 1 )(L 2 )(L 3 ), wherein R 1 =tert-butyl; L 1 =L 2 =pyridine; L 3 =pivalic acid; its single crystal being monoclinic, space group being P2 1 /c1, cell parameter being a=21.969(4)Å, b=25.326(5)Å, c=29.236(6)Å, α=90.00°, β=102.70(3)°, γ=90.00°, Z=8, volume being 15869(6)Å 3 ; and its structure being shown as in Formula I-2: or [Mn 4 CaO 4 (R 1 CO 2 ) 8 ](L 1 )(L 2 )(L 3 ), wherein R 1 =tert-butyl; L 1 =isoquinoline, L 2 =L 3 =pivalic acid; its single crystal being trigonal, space group being R-3, cell parameter being a=38.379(5)Å, b=38.379(5)Å, c=35.682(7)Å, α=90.00°, β=90.00°, γ=120.00°, Z=18, volume being 45517(12)Å 3 ; its structure being shown as in Formula I-3: 6. A process for preparing the [Mn 4 CaO 4 ](RCO 2 ) 8 (L 1 )(L 2 )(L 3 )-compound according to claim 1 , comprising: step 1: heating a mixture comprising an acid, an oxidant, a Mn 2+ salt, and a Ca 2+ salt at a molar ratio of (10-120):(2-8):1:1 in an acetonitrile solvent for 10-60 minutes to obtain a solution, filtering the solution to obtain a filtrate; crystallizing the filtrate at 0° C. to obtain crystals; step 2: dissolving the crystals obtained from step 1 in an ester solvent, and adding ligands L 1 , L 2 and L 3 to the ester solvent to cause recrystallization to obtain the [Mn 4 CaO 4 ](RCO 2 ) 8 (L 1 )(L 2 )(L 3 ) compound of claim 1 . 7. The preparation process according to claim 6 , wherein the Mn 2+ salt is selected from the group consisting of carboxylic acid salts of Mn 2+ ; wherein the carboxylic acid anion (R 1 CO 2 − ) is formate, acetate, propionate, butyrate, isobutyrate, valerate, isovalerate, pivalate, and hexanoate, Mn(ClO 4 ) 2 , MnSO 4 , Mn(NO 3 ) 2 , Mn(CF 3 SO 3 ) 2 , Mn(ClO 4 ) 2 (H 2 O) n , MnSO 4 (H 2 O) n , Mn(NO 3 ) 2 (H 2 O) n , and Mn(CF 3 SO 3 ) 2 (H 2 O) n , wherein n=1-5; the Ca 2+ salt is selected from the group consisting of carboxylic acid salts of calcium, wherein the carboxylic acid anion (R 1 CO 2 − ) is formate, acetate, propionate, butyrate, isobutyrate, valerate, isovalerate, pivalate, hexanoate Ca(ClO 4 ) 2 , Ca(NO 3 ) 2 , Ca(CF 3 SO 3 ) 2 , Ca(ClO 4 ) 2 (H 2 O) n , Ca(NO 3 ) 2 (H 2 O) n , Ca(CF 3 SO 3 ) 2 (H 2 O) n , wherein n=1-5; the oxidant is an permanganate anionic oxidant, the acid is acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, and hexanoic acid. 8. The preparation process according to claim 7 , wherein the oxidant is tetrabutylammonium permanganate ((C 4 H 9 ) 4 NMnO 4 ). 9. The preparation process according to claim 6 , characterized in that a volume of the acetonitrile solvent in step 1 is 60-100 ml acetonitrile per mmol calcium salt; the ester solvent in step 2 is ethyl acetate, methyl acetate, or propyl propionate. 10. The process according to claim 6 , wherein the [Mn 4 CaO 4 ](R 1 CO 2 ) 8 (L 1 )(L 2 )(L 3 ) compound is electrically neutral. 11. The process according to claim 6 , wherein, in the [Mn 4 CaO 4 ](R 1 CO 2 ) 8 (L 1 )(L 2 )(L 3 ) compound, R 1 is hydrogen (H), methyl (—CH 3 ), ethyl (—C 2 H 5 ), n-propyl (—CH 2 CH 2 CH 3 ), isopropyl (—CH(CH 3 ) 2 ), n-butyl, isobutyl, tert-butyl (—C(CH 3 ) 3 ), n-pentyl (—(CH 2 ) 4 CH 3 ), or isopentyl (—CH(CH 3 )C 2 H 5 ). 12. A method to splitting water, comprising: adding the [Mn 4 CaO 4 ](R 1 CO 2 ) 8 (L 1 )(L 2 )(L 3 ) compound of claim 1 to water to form a mixture; and adding an oxidant or applying an electric current to the mixture. 13. A water splitting catalyst comprising the [Mn 4 CaO 4 ](R 1 CO 2 ) 8 (L 1 )(L 2 )(L 3 ) compound according to claim 1 . 14. The water splitting catalyst according to claim 13 , wherein, the [Mn 4 CaO 4 ](R 1 CO 2 ) 8 (L 1 )(L 2 )(L 3 ) compound is electrically neutral. 15. The water splitting catalyst according to claim 13 , wherein R 1 is hydrogen (H), methyl (—CH 3 ), ethyl (—C 2 H 5 ), n-propyl (—CH 2 CH 2 CH 3 ), isopropyl (—CH(CH 3 ) 2 ), n-butyl, isobutyl, tert-butyl (—C(CH 3 ) 3 ), n-pentyl (—(CH 2 ) 4 CH 3 ), or isopentyl (—CH(CH 3 )C 2 H 5 ).
Calcium · CPC title
Bi- or polynuclear complexes, i.e. comprising two or more metal coordination centres, without metal-metal bonds, e.g. Cp(Lx)Zr-imidazole-Zr(Lx)Cp · CPC title
Bi- or polynuclear complexes, i.e. comprising two or more metal coordination centres, without metal-metal bonds, e.g. Cp(Lx)Zr-imidazole-Zr(Lx)Cp · CPC title
Bridging ligands, e.g. OAc in Cr2(OAc)4, Pt4(OAc)8 or dicarboxylate ligands · CPC title
Oxidation reactions, e.g. epoxidation, (di)hydroxylation, dehydrogenation and analogues · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.